Monday, November 16, 2026Every story links to its original source.

Genome News

Genomics news, traced to the source.

Reading

studyarchive1 min read

BRCA1 variants scored differently in two laboratory cell models

Illustrative photo by Towfiqu barbhuiya, Pexels LicenseImage licenceFull-size image

Nearly half of the BRCA1 variants that scored as losing function in the HAP1 laboratory cell model showed no measurable effect on BRCA1 function in an assay using human mammary epithelial cells (HMECs), another cell model. The researchers found that variants with conflicting scores retained partial gene function and conferred intermediate cancer risk. Their 2026 study compared the models to examine how the choice of cells affected the interpretation of BRCA1 variants.

Inherited disease-causing variants in BRCA1 predispose women to breast and ovarian cancer. More than half of reported single-nucleotide variants in the gene, changes affecting one DNA letter, lack a definitive clinical interpretation. Whether a variant has consistent effects across different cell types also remains largely unexplored.

The researchers used saturation genome editing (SGE), a method that tests the effects of changes to a gene by editing it in cells. In HAP1 cells, they scored 4,113 variants that had not previously been tested. They also developed an SGE assay in HMECs, allowing them to compare variant effects across cell lines, drug treatments and genetic backgrounds.

The team identified 538 variants that affected gene function through distinct mechanisms. Scores from HAP1 cells distinguished known disease-causing variants from benign variants with near-perfect accuracy. Yet nearly half of the variants scored as losing function in HAP1 cells received neutral scores in the HMEC assay, meaning they showed no measurable effect on BRCA1 function in that test.

The variants with conflicting scores were hypomorphic: they reduced gene function rather than eliminating it. They conferred intermediate cancer risk despite their neutral scores in HMECs. Comparing results from the two cell models improved the researchers' interpretation of how rare BRCA1 variants affect gene function.

Written by the Genomes desk from the primary source cited and linked above and checked against it. Research use only; not medical advice. Corrections: [email protected].

More from the archive

Back to the latest · Archive